U.S. market Closed. Opens in 5 hours 38 minutes

SIGA | SIGA Technologies, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 6.17 - 6.39
52 Week Range 4.26 - 12.83
Beta 0.92
Implied Volatility 101.70%
IV Rank 8.41%
Day's Volume 296,730
Average Volume 494,290
Shares Outstanding 71,404,700
Market Cap 451,277,704
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
IPO Date 1997-09-10
Valuation
Profitability
Growth
Health
P/E Ratio 5.27
Forward P/E Ratio 4.21
EPS 1.20
1YR Price Target N/A
Dividend Yield 7.23%
Dividend Per Share 0.46
Dividend ExDate N/A
Dividend PayDate N/A
Employees 45
Country USA
Website SIGA
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by the variola virus. Its products target orthopoxvirus infections including smallpox.
*Chart delayed
Analyzing fundamentals for SIGA we got that it has strong fundamentals where Valuation is considered to be significantly undervalued, Profitability is stunning wealthy, Growth is exceptionally good and Health is strong. For more detailed analysis please see SIGA Fundamentals page.

Watching at SIGA technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on SIGA Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙